# Study of CM310 in Adolescent Subjects With Atopic Dermatis

> **NCT06495229** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Keymed Biosciences Co.Ltd** · enrollment: 180 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **BIOLOGICAL:** CM310

## Key facts

- **NCT ID:** NCT06495229
- **Lead sponsor:** Keymed Biosciences Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-02
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06495229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06495229, "Study of CM310 in Adolescent Subjects With Atopic Dermatis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06495229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*